These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1714082)
1. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Hishikawa Y; Kurisu K; Taniguchi M; Kamikonya N; Miura T Radiother Oncol; 1991 Jun; 21(2):107-14. PubMed ID: 1714082 [TBL] [Abstract][Full Text] [Related]
2. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Okawa T; Dokiya T; Nishio M; Hishikawa Y; Morita K Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):623-8. PubMed ID: 10524414 [TBL] [Abstract][Full Text] [Related]
3. High-dose-rate intraluminal brachytherapy (HDRIBT) for esophageal cancer. Hishikawa Y; Kurisu K; Taniguchi M; Kamikonya N; Miura T Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1133-5. PubMed ID: 1938510 [TBL] [Abstract][Full Text] [Related]
4. Influence of intraluminal brachytherapy dose on complications in the treatment of esophageal cancer. Kumar MU; Swamy K; Supe SS; Anantha N Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1069-72. PubMed ID: 8262829 [TBL] [Abstract][Full Text] [Related]
5. Results of external irradiation and low-dose-rate intraluminal brachytherapy for esophageal cancer. Someya M; Sakata K; Saito A; Nagakura H; Oouchi A; Hareyama M Acta Oncol; 2002; 41(1):63-8. PubMed ID: 11990521 [TBL] [Abstract][Full Text] [Related]
6. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150 [TBL] [Abstract][Full Text] [Related]
7. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report. Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458 [TBL] [Abstract][Full Text] [Related]
8. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study. Sur RK; Levin CV; Donde B; Sharma V; Miszczyk L; Nag S Int J Radiat Oncol Biol Phys; 2002 May; 53(1):127-33. PubMed ID: 12007950 [TBL] [Abstract][Full Text] [Related]
9. Intracavitary brachytherapy combined with external-beam irradiation for squamous cell carcinoma of the thoracic esophagus. Hareyama M; Nishio M; Kagami Y; Narimatsu N; Saito A; Sakurai T Int J Radiat Oncol Biol Phys; 1992; 24(2):235-40. PubMed ID: 1526861 [TBL] [Abstract][Full Text] [Related]
10. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report. Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886 [TBL] [Abstract][Full Text] [Related]
11. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center. Bhatt L; Tirmazy S; Sothi S Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484 [TBL] [Abstract][Full Text] [Related]
12. Severe complications after hypofractionated high dose rate intracavitary brachytherapy following external beam irradiation for oesophageal carcinoma. Hama Y; Uematsu M; Shioda A; Suda A; Aida S; Kusano S Br J Radiol; 2002 Mar; 75(891):238-42. PubMed ID: 11932217 [TBL] [Abstract][Full Text] [Related]
13. High dose rate brachytherapy for superficial cancer of the esophagus. Maingon P; d'Hombres A; Truc G; Barillot I; Michiels C; Bedenne L; Horiot JC Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):71-6. PubMed ID: 10656375 [TBL] [Abstract][Full Text] [Related]
14. High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma. Yorozu A; Dokiya T; Oki Y Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):271-5. PubMed ID: 10487545 [TBL] [Abstract][Full Text] [Related]
15. External beam and intraluminal radiotherapy in the treatment of carcinoma of the esophagus. Hyden EC; Langholz B; Tilden T; Lam K; Luxton G; Astrahan M; Jepson J; Petrovich Z J Thorac Cardiovasc Surg; 1988 Aug; 96(2):237-41. PubMed ID: 3398546 [TBL] [Abstract][Full Text] [Related]
16. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases. Ghosh S; Sau S; Mitra S; Manna A; Ghosh K J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668 [TBL] [Abstract][Full Text] [Related]
17. Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation. Nishimura Y; Ono K; Tsutsui K; Oya N; Okajima K; Hiraoka M; Abe M Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1099-105. PubMed ID: 7961017 [TBL] [Abstract][Full Text] [Related]
18. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928 [TBL] [Abstract][Full Text] [Related]
19. Staging and prognosis using endosonography in patients with inoperable esophageal carcinoma treated with combined intraluminal and external irradiation. Tio LT; Blank LE; Wijers OB; den Hartog Jager FC; Van Dijk JD; Tytgat GN Gastrointest Endosc; 1994; 40(3):304-10. PubMed ID: 8056233 [TBL] [Abstract][Full Text] [Related]
20. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma. Muijs CT; Beukema JC; Mul VE; Plukker JT; Sijtsema NM; Langendijk JA Radiother Oncol; 2012 Feb; 102(2):303-8. PubMed ID: 21885139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]